This demonstrated that hereditary mutations in MMR genes can be found in patients with MSI-negative tumors, and also that patients with MSI-H colorectal cancer (CRC) or loss of MMR protein expression in their tumor may not necessarily show hereditary mutations in MMR genes through genetic testing, which would exclude the diagnosis of Lynch syndrome [16]. The gene discussed is MRC1; the disease is colorectal carcinoma.